These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9222041)

  • 1. Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, 'Israeli spotted fever group rickettsia' and Coxiella burnetii.
    Maurin M; Raoult D
    J Antimicrob Chemother; 1997 Jun; 39(6):725-30. PubMed ID: 9222041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin.
    Jabarit-Aldighieri N; Torres H; Raoult D
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2529-32. PubMed ID: 1336950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin.
    Maurin M; Raoult D
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2633-7. PubMed ID: 8109928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibilities of Coxiella burnetii, Rickettsia rickettsii, and Rickettsia conorii to the fluoroquinolone sparfloxacin.
    Raoult D; Bres P; Drancourt M; Vestris G
    Antimicrob Agents Chemother; 1991 Jan; 35(1):88-91. PubMed ID: 1901703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii.
    Rolain JM; Maurin M; Raoult D
    Antimicrob Agents Chemother; 2001 Jan; 45(1):301-2. PubMed ID: 11120982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis.
    Rolain JM; Maurin M; Bryskier A; Raoult D
    Antimicrob Agents Chemother; 2000 May; 44(5):1391-3. PubMed ID: 10770788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Rickettsia conorii and R. rickettsii to pefloxacin, in vitro and in ovo.
    Raoult D; Roussellier P; Vestris G; Galicher V; Perez R; Tamalet J
    J Antimicrob Chemother; 1987 Mar; 19(3):303-5. PubMed ID: 3106303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new serological test for the detection of anti-Coxiella and anti-Rickettsia antibodies.
    Bizzini A; Péter O; Baud D; Edouard S; Meylan P; Greub G
    Microbes Infect; 2015; 17(11-12):811-6. PubMed ID: 26432518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.
    Gikas A; Spyridaki I; Psaroulaki A; Kofterithis D; Tselentis Y
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2747-8. PubMed ID: 9756789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in-vitro anti-rickettsial activity of macrolides.
    Keysary A; Itzhaki A; Rubinstein E; Oron C; Keren G
    J Antimicrob Chemother; 1996 Oct; 38(4):727-31. PubMed ID: 8937968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii.
    Raoult D; Torres H; Drancourt M
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2070-7. PubMed ID: 1759829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice.
    Gong W; Wang P; Xiong X; Jiao J; Yang X; Wen B
    PLoS One; 2015; 10(4):e0124664. PubMed ID: 25909586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibilities of Rickettsia rickettsii and Rickettsia conorii to roxithromycin and pristinamycin.
    Drancourt M; Raoult D
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2146-8. PubMed ID: 2515795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antibodies against spotted fever group Rickettsia (SFGR), typhus group Rickettsia (TGR), and Coxiella burnetii in human febrile patients in the Philippines.
    Camer GA; Alejandria M; Amor M; Satoh H; Muramatsu Y; Ueno H; Morita C
    Jpn J Infect Dis; 2003 Feb; 56(1):26-8. PubMed ID: 12711823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of josamycin, spiramycin, and erythromycin against Rickettsia rickettsii and R. conorii.
    Raoult D; Roussellier P; Tamalet J
    Antimicrob Agents Chemother; 1988 Feb; 32(2):255-6. PubMed ID: 3129987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human spotted fever group rickettsioses are underappreciated in southern Taiwan, particularly for the species closely-related to Rickettsia felis.
    Lai CH; Chang LL; Lin JN; Tsai KH; Hung YC; Kuo LL; Lin HH; Chen YH
    PLoS One; 2014; 9(4):e95810. PubMed ID: 24755560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potentially involved proteins in levofloxacin resistance mechanisms in Coxiella burnetii.
    Vranakis I; De Bock PJ; Papadioti A; Tselentis Y; Gevaert K; Tsiotis G; Psaroulaki A
    J Proteome Res; 2011 Feb; 10(2):756-62. PubMed ID: 21070068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of minimum inhibitory concentration of several antibacterial agents against Rickettsia japonica using a plaque reduction assay system.
    Satoh M; Kato H; Takayama-Ito M; Ogawa M; Ando S; Saijo M
    J Infect Chemother; 2019 Nov; 25(11):917-919. PubMed ID: 31186196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.
    Spyridaki I; Psaroulaki A; Vranakis I; Tselentis Y; Gikas A
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2690-2. PubMed ID: 19332671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between Kawasaki syndrome and infection with Rickettsia conorii, Rickettsia typhi, Coxiella burnetii or Ehrlichia phagocytophila group.
    Kafetzis DA; Maltezou HC; Constantopoulou I; Antonaki G; Liapi G; Mathioudakis I
    Pediatr Infect Dis J; 2001 Jul; 20(7):703-6. PubMed ID: 11465844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.